WAYNE, Pa., June 5, 2015 /PRNewswire/ -- Ryan & Maniskas,
LLP is investigating potential claims against the board of
directors of Bio-Reference Laboratories Inc. ("Bio-Reference" or
the "Company") (NASDAQ: BRLI) concerning possible breaches of
fiduciary duty and other violations of law related to the Company's
efforts to sell the Company to OPKO Health, Inc. in a transaction
valued at approximately $1.47
billion.
If you own shares of Bio-Reference and would like to learn more
about this class action or if you wish to discuss these matters and
have any questions concerning this announcement or your rights,
contact Richard A. Maniskas, Esquire
toll-free at (877) 316-3218 or to sign up online, visit:
www.rmclasslaw.com/cases/brli. You may also email Mr.
Maniskas at rmaniskas@rmclasslaw.com.
Under the terms of the agreement, shareholders of Bio-Reference
will receive 2.75 shares of OPKO Health for each share of
Bio-Reference they own.
Our investigation concerns possible breaches of fiduciary duty
and other violations of state law by the Board of Directors of
Bio-Reference for not acting in the Company's shareholders' best
interests in connection with the sale process.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide. To learn more
about the class action process, please visit:
www.rmclasslaw.com.
CONTACT: Ryan & Maniskas,
LLP
Richard A. Maniskas,
Esquire
995 Old Eagle School Rd., Suite
311
Wayne, PA
19087
877-316-3218
www.rmclasslaw.com/cases/brli
rmaniskas@rmclasslaw.com
Logo -
http://photos.prnewswire.com/prnh/20121112/MM11729LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ryan--maniskas-llp-investigation-of-bio-reference-laboratories-inc-300094838.html
SOURCE Ryan & Maniskas, LLP